TANG CAPITAL MANAGEMENT LLC Q2 2020 Filing
Filed August 14, 2020
Portfolio Value
$1.0T
Holdings
21
Report Date
Q2 2020
Filing Type
13F-HR
All Holdings (21 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —ODONATE THERAPEUTICS INC | 14,075,269 | $595.9B | 57.94% | |
| 2 | —BIOHAVEN PHARMACEUTICAL HOLDING CO LTD | 980,461 | $71.7B | 6.97% | |
| 3 | RCKTROCKET PHARMACEUTICALS INC | 2,965,485 | $62.1B | 6.03% | |
| 4 | ANABANAPTYSBIO INC | 2,528,678 | $56.5B | 5.49% | |
| 5 | HRTXHERON THERAPEUTICS INC | 2,896,904 | $42.6B | 4.14% | |
| 6 | —LA JOLLA PHARMACEUTICAL CO | 8,695,474 | $37.0B | 3.60% | |
| 7 | BUWABIO RAD LABS INC | 80,000 | $36.1B | 3.51% | |
| 8 | UTHUNITED THERAPEUTICS CORP DEL | 200,000 | $24.2B | 2.35% | |
| 9 | RLMDRELMADA THERAPEUTICS INC | 500,000 | $22.4B | 2.18% | |
| 10 | PBYIPUMA BIOTECHNOLOGY INC | 1,365,376 | $14.2B | 1.38% | |
| 11 | GBYSANGAMO THERAPEUTICS INC | 1,578,795 | $14.1B | 1.38% | |
| 12 | —AVROBIO INC | 800,000 | $14.0B | 1.36% | |
| 13 | EGRXEAGLE PHARMACEUTICALS INC | 255,616 | $12.3B | 1.19% | |
| 14 | CHRSCOHERUS BIOSCIENCES INC | 550,000 | $9.8B | 0.95% | |
| 15 | —LIFESCI ACQUISITION CORP | 500,000 | $5.5B | 0.53% | |
| 16 | PRTAPROTHENA CORP PLC | 273,823 | $2.9B | 0.28% | |
| 17 | CTMXCYTOMX THERAPEUTICS INC | 300,000 | $2.5B | 0.24% | |
| 18 | VNDAVANDA PHARMACEUTICALS INC | 191,426 | $2.2B | 0.21% | |
| 19 | —RADIUS HEALTH INC | 119,005 | $1.6B | 0.16% | |
| 20 | —NUCANA PLC | 100,000 | $541.0M | 0.05% | |
| 21 | TENXTENAX THERAPEUTICS INC | 460,000 | $416.0M | 0.04% |